Pharmacy News

Today's Pharmaceutical and Pharmacy News

Daily News Topic:

FDA News

2/9/10 - Medical Acoustics Receives FDA 510k Clearance of Therapeutic Lung FluteÂ®

Medical Acoustics LLC, a commercial-stage medical device company which employs acoustic technologies for diagnostic and therapeutic medical applications, announced that it has received FDA 510 clearance of its Therapeutic Lung FluteÂ®. The application follows the successful completion of a clinical trial at the University at Buffalo and the Western

2/9/10 - US FDA Approves New Indication for CRESTOR(R) (rosuvastatin calcium)

WILMINGTON, Del., Feb. 8AstraZeneca today announced that the US Food and Drug Administration has approved CRESTORÂ® to reduce the risk of stroke, myocardial infarction and arterial revascularization procedures in individuals without clinically evident coronary heart disease but with an increased risk of cardiovascular disease based on age, high-sen

2/9/10 - YM BioSciences announces FDA clearance for two ongoing Phase II nimotuzumab trials into USA

YM BioSciences Inc., announced that the FDA has advised the Company that it may now enroll patients at US clinical sites into two ongoing randomized, double-blind Phase II trials of its lead product, nimotuzumab. The current trial designs were informed by previous trials with nimotuzumab in the same indications.

2/8/10 - Amneal Receives FDA Approval for Tramadol/APAP Tablets

Amneal Pharmaceuticals is pleased to announce that it received U.S. FDA approval to manufacture combination Tramadol HCl in 37.5 mg strength and Acetaminophen in 325 mg strength in tablet form effective December 9, 2009. Tramadol/APAP is a centrally-acting analgesic indicated for the short-term management of moderately severe acute pain.

2/8/10 - Atossa Genetics, Inc. Launches Corporate Web Site Featuring New FDA-Approved Breast Cancer Risk Assessment Test

02/08/10 -- Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer, announced today the launch of its new Web site at www.atossagenetics.com. Founded in 2009 by Steven C. Quay, M.D., Ph.D., Atossa Genetics, Inc. is comm

2/8/10 - Aubrey Inc. Receives FDA Clearance for AWBAT Plus

Aubrey Inc., an advanced wound care company, announced it has received clearance from the US Food and Drug Administration to market the AWBAT Plus product line in the United States. Like the initial AWBAT product line, AWBAT Plus consists of bioengineered wound dressings that are intended to close the wound and allow the body to heal in a moist env

Chain Drug Review

Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.

Featured Article from Chain Drug Review:

AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more